REGN
Regeneron Pharmaceuticals Inc
$664.54
-0.51%
-3.41
Notify me if price changes either direction
Buy REGN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
69.7B
Enterprise value
61.9B
Trailing PE
16.175581
Forward PE
12.344329
PEG Ratio
-2.0781509149153
Enterprise to EBITDA
14.125
Enterprise to revenue
4.15
Price to book MRQ
2.14835
Price to sales TTM
4.6545706
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
14.9B
EBITDA
5.1B
Diluted EPS TTM
40.95
Total Cash (MRQ)
8.8B
Current ratio (MRQ)
3.565
Operating Cash Flow (TTM)
5.0B
REGN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
